---
title: "Sunil Healthcare Ltd (537253) — Share Price, Financials & Analysis"
symbol: "537253"
company: "Sunil Healthcare Ltd"
canonical: "https://tapetide.com/stocks/537253"
isin: "INE671C01016"
nse_symbol: "SUNLOC"
bse_code: "537253"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 77.42
generated_at: "2026-09-13T19:38:24.021Z"
---

# Sunil Healthcare Ltd (537253)

Canonical page: https://tapetide.com/stocks/537253

## Company

- **NSE Symbol:** SUNLOC
- **BSE Code:** 537253
- **ISIN:** INE671C01016
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2026-08-17
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** sunilhealthcare.com

## About

Incorporated in 1976, Sunil Healthcare Ltd is a certified manufacturer of Empty Hard Gelatin capsules shell and HPMC Capsules shell.[1]

## Latest Price

- **Price:** ₹75.5
- **Change:** 0 (0%)
- **Open:** ₹75.7
- **Day High:** ₹75.7
- **Day Low:** ₹75
- **Previous Close:** ₹75.5
- **Volume:** 909
- **As Of:** 2026-09-11T08:59:20+00:00

## Key Fundamentals

Observed at 2026-09-11T04:46:00.968204Z.

- **Market Cap:** ₹77.42 Cr
- **Classification:** Microcap
- **P/E (reported):** 21.7
- **P/E (TTM):** 21.63
- **EPS (TTM):** ₹3.49
- **Book Value:** ₹51.56
- **Price to Book:** 1.46
- **Dividend Yield:** 0%
- **ROE:** -2.11%
- **ROCE:** 5.28%
- **Debt to Equity:** 0.8
- **Revenue (yearly):** ₹87.72 Cr
- **Net Income:** ₹1.84 Cr
- **EBITDA:** ₹12.65 Cr
- **52-Week High:** ₹82
- **52-Week Low:** ₹67.5
- **RSI (14):** 47.85

## Tapetide Score

- **Score:** 57 / 100
- **Score date:** 2026-09-04
- **Archetype:** Quality at a Reasonable Price
- **What it means:** Financial strength is not being paid for with a demanding multiple. The question worth asking is whether the quality is durable or reflects a good patch — check the consistency of returns over several years rather than the latest quarter.
- **Pillar profile:** Quality: Good · Valuation: Cheap · Momentum: Rising
- **Percentile:** 77.8 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 20.93 | 9% |
| growth | 35.55 | 9% |
| momentum | 83.82 | 12% |
| ownership | 50 | 24% |
| quality | 70.89 | 22% |
| valuation | 61.13 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Stock is trading at 1.11 times its book value

### Weaknesses

- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -0.65% over past five years.
- Company has a low return on equity of 0.59% over last 3 years.
- Company has high debtors of 188 days.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 174.81% | 54.22% | -32.2% |
| ebitda margin growth | 45.45% | 2.78% | 44.16% | -10.78% |
| net income growth | -66.67% | -231.43% | -15% | 55% |
| revenue growth | -4.48% | 3.44% | -7% | -1% |
| roce | 139.44% | 66.04% | -70.88% | 10.39% |
| roe | -69.74% | -19.47% | 2.4% | 44.52% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 23.7 | 22.67 | 21.31 | 21.5 | 20.26 | 20.46 | 21.2 | 22.64 | 23.52 | 21.84 | 19.72 | 18.99 |
| Expenses | 22.48 | 23.3 | 18.63 | 19.29 | 17.95 | 17.76 | 18.17 | 19.37 | 19.59 | 18.22 | 17.78 | 16.06 |
| Operating Profit | 1.22 | -0.63 | 2.68 | 2.21 | 2.31 | 2.7 | 3.03 | 3.27 | 3.93 | 3.62 | 1.94 | 2.93 |
| OPM % | 5.15 | -2.78 | 12.58 | 10.28 | 11.4 | 13.2 | 14.29 | 14.44 | 16.71 | 16.58 | 9.84 | 15.43 |
| Other Income | 0.22 | 3.13 | 0.68 | 0.14 | 0.18 | 0.53 | 0.49 | 0.86 | 0.42 | 0.5 | 0.29 | 0.23 |
| Interest | 1.31 | 1.44 | 1.76 | 1.51 | 1.5 | 1.89 | 1.56 | 1.44 | 1.4 | 1.66 | 1.66 | 1.5 |
| Depreciation | 1.59 | 1.45 | 1.43 | 1.48 | 1.51 | 1.69 | 1.68 | 1.66 | 1.64 | 1.62 | 1.52 | 1.46 |
| Profit before tax | -1.46 | -0.39 | 0.17 | -0.64 | -0.52 | -0.35 | 0.28 | 1.03 | 1.31 | 0.84 | -0.95 | 0.2 |
| Tax % | -25.34 | -48.72 | 5.88 | 6.25 | 7.69 | 57.14 | -28.57 | 11.65 | 23.66 | 30.95 | -258.95 | -130 |
| Net Profit | -1.1 | -0.2 | 0.15 | -0.69 | -0.55 | -0.54 | 0.36 | 0.91 | 1 | 0.59 | 1.52 | 0.46 |
| EPS in Rs | -1.07 | -0.2 | 0.15 | -0.67 | -0.54 | -0.53 | 0.35 | 0.89 | 0.98 | 0.58 | 1.48 | 0.45 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 91.33 | 80.88 | 70.02 | 90.62 | 119.16 | 110.49 | 90.19 | 83.42 | 87.72 | 84.07 |
| Expenses | 77.44 | 69.62 | 76.95 | 85.27 | 101.78 | 94.32 | 85.93 | 73.06 | 74.95 | 71.65 |
| Operating Profit | 13.89 | 11.26 | -6.93 | 5.35 | 17.38 | 16.17 | 4.26 | 10.36 | 12.77 | 12.42 |
| OPM % | 15.21 | 13.92 | -9.9 | 5.9 | 14.59 | 14.63 | 4.72 | 12.42 | 14.56 | 14.77 |
| Other Income | 2.23 | 0.18 | 14.41 | 5.52 | 1.68 | 4.5 | 5.05 | 1.24 | 2.06 | 1.44 |
| Interest | 5.03 | 6.58 | 6.95 | 5.31 | 3.49 | 4.17 | 5.78 | 6.46 | 6.16 | 6.22 |
| Depreciation | 4.78 | 5.74 | 6.13 | 6.11 | 6.31 | 7.01 | 6.09 | 6.35 | 6.44 | 6.24 |
| Profit before tax | 6.31 | -0.88 | -5.6 | -0.55 | 9.26 | 9.49 | -2.56 | -1.21 | 2.23 | 1.4 |
| Tax % | 28.68 | -20.45 | -11.25 | 16.36 | 30.67 | 29.5 | -30.08 | 16.53 | -79.37 | — |
| Net Profit | 4.49 | -0.69 | -4.96 | -0.64 | 6.42 | 6.68 | -1.79 | -1.42 | 4.01 | 3.57 |
| EPS in Rs | 4.38 | -0.67 | -4.84 | -0.62 | 6.26 | 6.51 | -1.75 | -1.38 | 3.91 | 3.49 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 |
| Reserves | 32.65 | 37.18 | 36.52 | 34.34 | 33.46 | 39.7 | 45.74 | 57.96 | 56.81 | 59.35 |
| Borrowings | 44.53 | 60.62 | 55.08 | 49.45 | 49.82 | 34.68 | 36.79 | 66.15 | 68.65 | 55.79 |
| Other Liabilities | 31.41 | 34.16 | 35.88 | 36.19 | 27.03 | 25.06 | 28.01 | 24.13 | 26.23 | 39.12 |
| Total Liabilities | 118.84 | 142.21 | 137.73 | 130.23 | 120.56 | 109.69 | 120.79 | 158.49 | 161.94 | 164.51 |
| Fixed Assets | 59.72 | 70.92 | 68.83 | 69.97 | 69.8 | 69.97 | 70.43 | 87.16 | 94.08 | 85.85 |
| CWIP | 0.12 | 0.19 | 2.47 | 0.01 | 0.01 | 1.75 | 0.01 | 5.66 | 0.09 | 1.77 |
| Investments | 0 | 0.1 | 0.11 | 0.11 | 1.07 | 1.03 | 0 | 0 | 0 | 0 |
| Other Assets | 59 | 71 | 66.32 | 60.14 | 49.68 | 36.94 | 50.35 | 65.67 | 67.77 | 76.89 |
| Total Assets | 118.84 | 142.21 | 137.73 | 130.23 | 120.56 | 109.69 | 120.79 | 158.49 | 161.94 | 164.51 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 10.79 | 5.48 | 14.73 | 4.31 | 16.99 | 22.51 | 7.47 | -15.4 | 11.52 | 22.15 |
| Cash from Investing Activity | -12.85 | -17.18 | -2.8 | -2.52 | -11.36 | -4.24 | -3.4 | -10.11 | -7.7 | -2.85 |
| Cash from Financing Activity | 2.23 | 11.02 | -11.63 | -1.56 | -6.42 | -18.56 | -3.75 | 25 | -3.87 | -19.26 |
| Net Cash Flow | 0.17 | -0.67 | 0.3 | 0.23 | -0.79 | -0.29 | 0.32 | -0.51 | -0.05 | 0.04 |
| Free Cash Flow | -2.15 | -10.13 | 9.22 | 3.63 | 10.28 | 13.49 | 3.99 | -25.58 | 2.52 | 18.6 |
| CFO/OP | 82 | 50 | 134 | -64 | 315 | 136 | 55 | -344 | 111 | 173 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 129.57 | 192.39 | 177.08 | 122.81 | 94.37 | 57.86 | 93.85 | 164.27 | 182.19 | 187.78 |
| Inventory Days | 76.09 | 101.63 | 213.19 | 322.8 | 117.09 | 83.25 | 105.15 | 110.57 | 175.58 | 208.67 |
| Days Payable | 138.91 | 180.29 | 294.23 | 292.81 | 109.16 | 65.01 | 114.04 | 47.85 | 88.79 | 177.93 |
| Cash Conversion Cycle | 66.75 | 113.73 | 96.04 | 152.81 | 102.3 | 76.09 | 84.96 | 226.99 | 268.99 | 218.52 |
| Working Capital Days | -11.68 | -16.43 | -50.91 | -63.65 | -53.49 | -25.91 | -4.33 | 6.35 | -2.54 | 21.6 |
| ROCE % | — | 11.6 | 5.43 | 1.65 | 5.12 | 14.25 | 15.3 | 2.98 | 3.96 | 6.52 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 17.58% | 17.66% | 17.68% | 17.79% | 17.8% | 17.82% | 17.85% | 17.84% | 17.85% | 17.85% | 17.84% | 17.89% |
| Others | 8.79% | 8.71% | 8.69% | 8.58% | 8.57% | 8.55% | 8.52% | 8.52% | 8.52% | 8.52% | 8.53% | 8.48% |
| No. of Shareholders | 7081 | 7010 | 6858 | 6594 | 6507 | 6550 | 6541 | 6475 | 6430 | 6399 | 6364 | 6310 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 11 / 5 / 3

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 78.88 | Sell |
| EMA (10) | 77.01 | Sell |
| SMA (20) | 74.49 | Buy |
| EMA (20) | 75.45 | Buy |
| SMA (50) | 71.83 | Buy |
| EMA (50) | 72.3 | Buy |
| SMA (100) | 68.07 | Buy |
| EMA (100) | 70.08 | Buy |
| SMA (200) | 67.84 | Buy |
| EMA (200) | 69.66 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 52.54 | Neutral |
| MACD (12,26,9) | 2.1 | Sell |
| Stochastic (14,3,3) | 60.33 | Neutral |
| ADX (14) | 39.83 | Buy |
| Williams %R (14) | -46.43 | Neutral |
| ATR (14) | 2.9 | High Volatility |
| ROC (12) | 7.86 | Buy |
| Stoch RSI (14) | 10.54 | Buy |
| UO (7,14,28) | 51.14 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-03 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72487215-be9e-4043-8d22-80e12a1bad9c.pdf) |
| 2026-09-02 | [Notice Of 52Nd Annual General Meeting Of The Company/Remote E-Voting Facility/E-Voting Facility And Other Information](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f8595be-cd7c-4a65-8e7d-825f98532272.pdf) |
| 2026-09-02 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4b16eb2e-9822-40a0-8756-fe249cf27f9d.pdf) |
| 2026-08-21 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=caaed387-2a95-467e-8a89-bfd4967f37e1.pdf) |
| 2026-08-15 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b2cdd24-2019-4202-a3db-cdaba1d7ee0b.pdf) |
| 2026-08-13 | [Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca989d28-bac1-40c2-9588-3fdaf85888c3.pdf) |
| 2026-07-31 | [Board Meeting Intimation for Intimation Of The Board Meeting Scheduled To Be Held On 13.08.2026 Pursuant To Regulation 29 Read With Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=640494d1-3930-4d21-a7cd-f481062cb674.pdf) |
| 2026-07-06 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41d33b4a-b38b-45e8-b0d1-0f3e55fc1771.pdf) |
| 2026-06-30 | [Special Window For Transfer And Dematerialisation (Demat) Of Physical Securities](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d76482b-a839-4005-8a64-db0d21ab1a0b.pdf) |
| 2026-06-26 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0443e273-6f04-4038-ac25-84078eb99855.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-13 | [Approved Un-Audited Financial Results For The 1St Quarter Of FY 2026-27 Ended On 30.06.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c526df2f-89ea-4fa0-a565-16185f916ca0.pdf) |
| 2026-05-29 | [Approved Audited Financial Results (Standalone And Consolidated) For The Quarter/Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4fe4437a-8fe7-4d35-8652-d68f7dae7f51.pdf) |
| 2026-05-29 | [Approved Audited Financial Results (Standalone And Consolidated) For The Quarter/Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1acec4c-b030-4756-ab52-684bbd0ce472.pdf) |
| 2026-02-06 | [Unaudited Financial Results (Both Standalone And Consolidated) For The Quarter And Nine Months Ended 31.12.2025 Of FY 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0250a66e-e828-42d3-828a-d842a4d20e09.pdf) |
| 2025-11-04 | [Unaudited Financial Results (Both Standalone And Consolidated) For The Quarter/Half Tear Ended 30.09.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32eb2800-8a9a-4e1d-8036-458be4c913d2.pdf) |
| 2025-07-30 | [Un-Audited Financial Results For The Quarter Ended 30.06.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1444d033-ed72-4804-a5f2-716ad0c44b02.pdf) |
| 2025-05-29 | [Financial Results For The Quarter/Year Ended 31.03.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b18aeda6-3a8a-413e-8de7-e0a119489be6.pdf) |
| 2025-02-13 | [Un-Audited Financial Results (Standalone And Consolidated) For 3Rd Quarter/ Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06088ff0-8a97-4f0f-b82a-1b0906a5cc9d.pdf) |
| 2024-11-13 | [Un-Audited Financial Results (Standalone And Consolidated) For The 2Nd Quarter/ 1St Half Year Of The FY 2024-25 Ended On September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0b39a1e-5bda-4a7b-89d5-7da747e47641.pdf) |
| 2024-08-13 | [Un-Audited Financial Results (Both Standalone And Consolidated) For The 1St Quarter Of The Financial Year 2024-25 Ended On June 30, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d8b8196e-65a6-4469-9f12-2c67c9346b7c.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8 Feb - Newspaper clippings regarding publication of un-audited financial results for 3rd quarter/9 months ended 31st December 2025 (both standalone and consolidated) | [Announcement under Regulation 30 (LODR)-Newspaper Publication 8 Feb - Newspaper clippings regarding publication of un-audited financial results for 3rd quarter/9 months ended 31st December 2025 (both standalone and consolidated)](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dceb20f6-66aa-4c48-bdff-5562fe910575.pdf) |
| 7 Jan - Compliance certificate under Regulation 74(5) of SEBI (DP) regulations 2018 for quarter ended 31.12.2025 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Jan - Compliance certificate under Regulation 74(5) of SEBI (DP) regulations 2018 for quarter ended 31.12.2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0b740b40-ac60-4682-b4ef-3d6d65660ad4.pdf) |
| 7 Apr - Sunil Healthcare filed Reg. 74(5) compliance certificate for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Apr - Sunil Healthcare filed Reg. 74(5) compliance certificate for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9d309891-76ad-479e-a4c1-9cbb5a41f1c1.pdf) |
| 6 Feb - Board approved unaudited standalone and consolidated Q3/9M results for period ended Dec 31, 2025; limited review attached. | [Board Meeting Outcome for Outcome Of The Board Meeting Held On 06.02.2026 6 Feb - Board approved unaudited standalone and consolidated Q3/9M results for period ended Dec 31, 2025; limited review attached.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/36cfb86a-c11f-48ad-8a00-4283fd04958e.pdf) |
| 6 Feb - Board approved unaudited standalone and consolidated Q3/9M results ended December 31, 2025; limited review enclosed. | [Unaudited Financial Results (Both Standalone And Consolidated) For The Quarter And Nine Months Ended 31.12.2025 Of FY 2025-26 6 Feb - Board approved unaudited standalone and consolidated Q3/9M results ended December 31, 2025; limited review enclosed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0250a66e-e828-42d3-828a-d842a4d20e09.pdf) |
| 28 Jan - Board meeting Feb 06, 2026 to approve Q3/9M unaudited results for period ended Dec 31, 2025. | [Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (LODR) Regulations, 2015 28 Jan - Board meeting Feb 06, 2026 to approve Q3/9M unaudited results for period ended Dec 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dd5e4666-5b63-4409-90f8-4f0c05011244.pdf) |
| 24 Apr - Sunil Healthcare confirms it is not a Large Corporate; FY26 borrowing was Rs19.08 crore. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 24 Apr - Sunil Healthcare confirms it is not a Large Corporate; FY26 borrowing was Rs19.08 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3fd01e92-05fb-4e97-853f-2cf6933d78aa.pdf) |
| 13h - Sunil Healthcare confirms it is not a Large Corporate; FY26 borrowing was Rs19.08 crore. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 13h - Sunil Healthcare confirms it is not a Large Corporate; FY26 borrowing was Rs19.08 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/3fd01e92-05fb-4e97-853f-2cf6933d78aa.pdf) |
| — | [Compliance Certificate Under Regulation 40 (10) Of SEBI LODR For The Year Ended 31St March 2026 16 Apr](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0381a1e8-e21d-4148-a2b2-2266285d7bcf.pdf) |
| — | [Closure of Trading Window 27 Mar](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5cbfe09f-0fe0-4d20-a5dd-36358fe5bb2e.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2013 from nse](https://archives.nseindia.com/annual_reports/AR_1485_MEGH_2012_2013_23092013094452.zip) |
| from nse | [Financial Year 2009 from nse](https://archives.nseindia.com/annual_reports/AR_MEGH_2008_2009_14082009113543.zip) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6dc8d21e-f4b1-4faa-9d67-95d8343d58c2.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3f322096-1bd6-45db-9a66-fd16137fec88.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b81b0de1-2d4c-4ca4-8f5a-aeadfdead288.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/537253/75048537253.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/537253/71615537253.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/532865/5328650320.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/537253/66364537253.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/537253/5372530319.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2018 | [Concall - Sep 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=efdca5ab-f55a-4b92-8826-523e23587892.pdf) |
| Sep 2018 | [Concall - Sep 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/9/efdca5ab-f55a-4b92-8826-523e23587892.pdf) |
| Oct 2018 | [Concall - Oct 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/10/5eb1dd6f-4784-4ee9-9dbe-a94b86164325.pdf) |
| Nov 2020 | [Concall - Nov 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/59ad4dde-bef3-4952-88d0-ae3c59ab29c0.pdf) |
| Nov 2019 | [Concall - Nov 2019](https://www.bseindia.com/xml-data/corpfiling/AttachHis/421e5171-b940-4030-be06-34a9419442fd.pdf) |
| Nov 2018 | [Concall - Nov 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1cab574-f51f-40c9-ac93-b4017070f968.pdf) |
| Nov 2018 | [Concall - Nov 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/11/b1cab574-f51f-40c9-ac93-b4017070f968.pdf) |
| Nov 2016 | [Concall - Nov 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=FEB0B7B1_6793_46FF_9678_F9F1A417233B_153928.pdf) |
| Nov 2016 | [Concall - Nov 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2448DF7A_C3E1_4D1A_A03A_0827A7A6C0A6_163248.pdf) |
| Nov 2015 | [Concall - Nov 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=AB40E856_7DB9_4145_ACA7_3C155EFA1937_142134.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:38:24.021Z.